Healthcare - Biotechnology - NASDAQ - US
$ 3.22
-2.72 %
$ 272 M
Market Cap
-1.56
P/E
INCOME STATEMENT
0
REVENUE
-164 M
OPERATING INCOME
-136 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Atea Pharmaceuticals, Inc.
| Revenue | 0 |
| Cost Of Revenue | 70.1 M |
| Gross Profit | -70.1 M |
| Operating Expenses | 94.1 M |
| Operating Income | -164 M |
| Other Expenses | -28.2 M |
| Net Income | -136 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 0 | 0 | 351.4 | 48.6 | 0 | 0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 70.1 | 0.3 | 29 K | 19 K | 17 K | 17 K |
| Gross Profit | (70.1) | (0.3) | 351.3 | 48.6 | 17 K | 17 K |
| OPERATING INCOME | ||||||
| Operating Expenses | 94.1 | 130.7 | 213.0 | 59.7 | 14.6 | 9.5 |
| Selling, General and Administrative Expenses | 49.9 | 48.7 | 45.8 | 21.6 | 4.4 | 2.8 |
| Research and Development Expenses | 132.8 | 81.9 | 167.2 | 38.0 | 10.2 | 6.7 |
| Operating Income | (164.2) | (130.7) | 138.4 | (11.0) | (14.6) | (9.5) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0 | 11.2 | 0 | 0 | 0 | 0 |
| Total Other Income | 29.2 | 11.2 | 0.2 | 83 K | 0.6 | 0.4 |
| Pre-Tax Income | (134.9) | (119.5) | 138.6 | (10.9) | (14.0) | (9.1) |
| NET INCOME | ||||||
| Tax Provision | 1.0 | (3.6) | 17.4 | 83 K | (0.6) | 0.4 |
| Net Income | (136.0) | (115.9) | 121.2 | (10.9) | (13.5) | (9.1) |
| EPS | 1.63 | 1.39 | 1.46 | 0.13 | 0.16 | 0.19 |